Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Histogen
company
About
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
- 11 - 50
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $6M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets. It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$41.91M
Histogen has raised a total of
$41.91M
in funding over 2 rounds. Their latest funding was raised on
Mar 17, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 17, 2017 | Grant | $750K | 1 |
National Science Foundation
|
— | Detail |
| Aug 17, 2016 | Series D | $6M | 1 |
|
— | Detail |
| Jun 29, 2015 | Series C | $24.90M | 1 | — | — | Detail |
| Jun 26, 2015 | Grant | $269.99K | 1 |
National Science Foundation
|
— | Detail |
| Dec 1, 2010 | Series A | $10M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
4
3
Histogen is funded by 3 investors.
National Science Foundation
and Pineworld Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
|
Yes | Series D |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
